Question 1

What is Insulin degludec?

Accepted Answer

Insulin degludec is a long-acting form of insulin used to help regulate blood sugar levels. It is commonly associated with the management of diabetes mellitus, including both type 1 and type 2 diabetes. This medication is designed to provide a steady level of insulin over an extended period. Its prolonged action helps support stable glucose control throughout the day and night.

Question 2

What is Insulin degludec used for?

Accepted Answer

Insulin degludec is used to treat diabetes mellitus .

Question 3

How does Insulin degludec work?

Accepted Answer

Mechanism of Action

Insulin degludec is an ultra-long-acting basal insulin. It works by replacing the insulin that the body normally produces, helping to regulate blood sugar levels in people with diabetes.

This medication performs several key functions in the body:

Glucose Transport: It helps move sugar from the bloodstream into other body tissues, such as muscle and fat cells, where it can be used for energy.

Liver Regulation: It signals the liver to stop producing and releasing more sugar into the blood.

Metabolic Support: It assists the body in properly processing fats and proteins.

Duration of Effect

Unlike short-acting insulins, insulin degludec is designed to release slowly into the bloodstream. After it is injected under the skin, it forms a depot that provides a steady, continuous level of insulin for a long period. This helps maintain stable blood sugar levels between meals and overnight, with effects that can last for 42 hours or more.

Question 4

What are the brand names for Insulin degludec?

Accepted Answer

Insulin degludec is sold under the brand name Tresiba .

Question 5

What are the active ingredients in Insulin degludec?

Accepted Answer

The active ingredient in Insulin degludec is insulin degludec .

Question 6

What are the side effects of Insulin degludec?

Accepted Answer

Common side effects of Insulin degludec may include:

Hypoglycemia

Weight gain

Injection site reactions

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Insulin degludec?

Accepted Answer

Insulin degludec belongs to the long-acting insulin drug class.

Question 8

What is the dosage of Insulin degludec and how do I take it?

Accepted Answer

Insulin degludec is injected under the skin (subcutaneously) into the thigh, upper arm, or abdominal area. It is typically used once per day. While it is best to take it at the same time each day, the timing can be flexible as long as there are at least 8 hours between doses.

Administration Tips

Always check the insulin label before use to ensure you have the correct type and strength.

The solution should be clear and colorless; do not use it if it is cloudy, colored, or contains particles.

Rotate the injection site within the same body region for each dose to reduce the risk of skin thickening, pits, or lumps.

Do not inject into skin that is tender, bruised, scaly, hard, scarred, or damaged.

Use a new needle for every injection. Never share your insulin pen or syringes with others, even if the needle has been changed.

Do not mix insulin degludec in the same syringe with any other insulin or liquid.

Missed Dose

If you miss a dose, take it as soon as you remember, ensuring there is a minimum of 8 hours between the missed dose and your next scheduled dose. After that, you can return to your regular once-daily schedule.

Question 9

Is Insulin degludec safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Maintaining stable blood glucose levels is essential during pregnancy to reduce the risk of complications for both the parent and the developing baby. Clinical studies have not shown an increased risk of major birth defects or other adverse outcomes when insulin degludec is used during pregnancy compared to other long-acting insulins.

Insulin requirements typically fluctuate throughout the course of pregnancy and the period immediately following delivery:

First trimester: Insulin needs may decrease.

Second and third trimesters: Insulin needs usually increase.

Postpartum: Insulin requirements often drop rapidly after the baby is born.

Breastfeeding

Insulin degludec is generally considered safe to use while breastfeeding. Because insulin is a naturally occurring hormone in the body, it is not expected to cause harm to a nursing infant. However, breastfeeding can affect blood sugar levels, and insulin doses may need to be adjusted during the postpartum period.

It is important to discuss any plans for pregnancy or breastfeeding with a healthcare provider to ensure blood sugar levels are monitored closely and medication doses are managed appropriately.

Question 10

What forms and strengths does Insulin degludec come in?

Accepted Answer

Insulin degludec is a solution for subcutaneous injection. It is available in the following formats:

Prefilled disposable pens

Multi-dose vials

Insulin degludec is also available in combination with other medications, including:

Insulin degludec and insulin aspart, provided in prefilled pens.

Insulin degludec and liraglutide, provided in prefilled pens.

Question 11

What is the FDA approval status of Insulin degludec?

Accepted Answer

FDA Approval and Indications

Insulin degludec was approved by the U.S. Food and Drug Administration (FDA) in 2015. It is indicated to improve glycemic control in adults and pediatric patients aged 1 year and older with diabetes mellitus. It is available as a standalone long-acting insulin and in combination with other medications, such as insulin aspart or liraglutide.

Safety Monitoring and Communications

The FDA monitors the safety of insulin degludec through the FDA Adverse Event Reporting System (FAERS). The following safety signals have been identified:

Medication Errors: In 2018 and 2020, the FDA identified potential signals regarding medication errors, including instances of the wrong drug or wrong dose being administered. The FDA evaluated these reports to determine if regulatory action or changes to the labeling were necessary.

Regulatory Requirements

Insulin degludec does not currently have a Boxed Warning or a Risk Evaluation and Mitigation Strategy (REMS) program. It is classified as a prescription-only medication.

Question 12

What should I know about Insulin degludec and cost?

Accepted Answer

The price of insulin degludec can vary significantly based on the following factors:

Generic vs. Brand Name: Insulin degludec is available as a brand-name medication and as a generic. Generic versions are often more affordable than brand-name products.

Insurance Coverage: Out-of-pocket costs are largely determined by a patient's health insurance plan, including its formulary status, deductibles, and copayments. Some insurance plans may only cover specific brands or versions of the drug.

Pharmacy Selection: Prices may differ between retail pharmacies, mail-order pharmacies, and local providers.

Dosage and Packaging: The cost is affected by the concentration of the insulin (such as U-100 or U-200) and whether it is dispensed in vials or pre-filled pens.

Patients who are uninsured or underinsured may be able to access patient assistance programs or manufacturer savings cards to help reduce costs. It is advisable to consult with a pharmacist or insurance provider to determine the exact cost for a specific prescription.

Insulin degludec

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?